BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3551220)

  • 1. Effect of cyclosporine A on risk factors in renal transplantation.
    Disney AP
    Transplant Proc; 1987 Apr; 19(2):2829-33. PubMed ID: 3551220
    [No Abstract]   [Full Text] [Related]  

  • 2. No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience.
    Brynger H; Persson H; Flatmark A; Albrechtsen D; Frödin L; Tufvesson G; Gäbel H; Weibull H; Möller E; Lundgren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):261-3. PubMed ID: 3291253
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors influencing the result of kidney transplantation with special reference to the HLA system in conventional immunosuppression].
    Wegener S; Auner M; Templin R; Schmitt E; Erdmann T; Fünfhausen G
    Z Urol Nephrol; 1990 Aug; 83(8):431-8. PubMed ID: 2238884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cyclosporine improve the results of HLA-identical renal transplantation?
    Flechner SM; Kerman RH; Van Buren CT; Lorber MI; Barker CJ; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1485-8. PubMed ID: 3547866
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine.
    Albrechtsen D; Flatmark A; Leivestad T; Brynger H; Frødin L; Groth CG; Lundgren G; Persson N
    Transplant Proc; 1990 Feb; 22(1):214-5. PubMed ID: 2408207
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Lindholm A; Maurer W; Möller E; Persson H
    Transplant Proc; 1987 Oct; 19(5):3614-8. PubMed ID: 3313870
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of HLA matching and lymphocytotoxic antibody status in heart-lung allograft recipients receiving cyclosporin and azathioprine.
    Festenstein H; Banner N; Smith J; Awad J; Burden M; Fitzgerald N; Holmes J; Khaghani A; Smith J; McCloskey D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):797-8. PubMed ID: 2495632
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment protocols: is there a role for tissue typing in renal transplantation?
    Ferguson RM
    Transplant Proc; 1988 Dec; 20(6 Suppl 8):42-5. PubMed ID: 3059621
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of suppressor cells in cyclosporine-treated allograft recipients.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1580-3. PubMed ID: 2950632
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-A, -B, and -DR matching and preoperative transfusions in renal transplantation.
    Reinitz ER; Rhodes C; Ellis T; Goldman MH; Bacquero A; Mendez-Picon G; Lee HM; Carter WH; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1415-8. PubMed ID: 6390840
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cyclosporine immunosuppression in humans.
    Kerman RH
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):143-52. PubMed ID: 3284064
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-specific blood transfusion reduces cyclosporine effect on the survival of canine renal allografts.
    Dienst SG; Amprim FL; Schervish E
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1102-4. PubMed ID: 3291219
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion of one HLA-DR antigen-matched blood to potential recipients of a renal allograft.
    Middleton D; Martin J; Douglas J; McClelland M
    Transplantation; 1994 Oct; 58(7):845-8. PubMed ID: 7940720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DR phenotype matching and transfusion in patients treated with cyclosporine.
    Cicciarelli J; Terasaki PI
    Transplant Proc; 1988 Dec; 20(6):1082-3. PubMed ID: 3201554
    [No Abstract]   [Full Text] [Related]  

  • 17. Japanese Multicenter Trial of Cyclosporine in Renal Transplantation: overall results and analysis of the factors influencing graft survival rate.
    Ochiai T; Toma H; Takagi H; Oka T; Ishibashi M; Kashiwabara H; Fukao K; Ota K; Hashimoto I; Sonoda T
    Transplant Proc; 1987 Apr; 19(2):2961-6. PubMed ID: 3551242
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine inhibits nonspecific transfusion-induced immunity in dogs.
    Kyriakides GK; Esquenazi V; Olson L; Milgrom M; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1432-3. PubMed ID: 2978877
    [No Abstract]   [Full Text] [Related]  

  • 19. Multicenter impact of ciclosporin on cadaver kidney graft survival.
    Opelz G
    Prog Allergy; 1986; 38():329-45. PubMed ID: 3523494
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
    Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
    Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.